Search
Now showing items 1-1 of 1
Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022)
(2022)
Abstract:
Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many ...